Disclosing genetic risk for Alzheimer's dementia to individuals with mild cognitive impairment

INTRODUCTION: The safety of predicting conversion from mild cognitive impairment (MCI) to Alzheimer's disease (AD) dementia using apolipoprotein E (APOE) genotyping is unknown. METHODS: We randomized 114 individuals with MCI to receive estimates of 3‐year risk of conversion to AD dementia infor...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Alzheimers Dement (N Y)
Asıl Yazarlar: Christensen, Kurt D., Karlawish, Jason, Roberts, J. Scott, Uhlmann, Wendy R., Harkins, Kristin, Wood, Elisabeth M., Obisesan, Thomas O., Le, Lan Q., Cupples, L. Adrienne, Zoltick, Emilie S., Johnson, Megan S., Bradbury, Margaret K., Waterston, Leo B., Chen, Clara A., Feldman, Sara, Perry, Denise L., Green, Robert C.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2020
Konular:
Research Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7087414/
https://ncbi.nlm.nih.gov/pubmed/32211507
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/trc2.12002
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller